Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Working Capital Raise

23 Dec 2015 13:00

RNS Number : 0644K
Fitbug Holdings PLC
23 December 2015
 

 

Fitbug Holdings Plc / Epic: FITB.L / Index: AIM / Sector: Leisure

23 December 2015

FITBUG HOLDINGS PLC ('FITBUG' OR 'THE COMPANY')

FURTHER WORKING CAPITAL RAISE

 

Fitbug Holdings Plc, the AIM quoted provider of online personal health and wellbeing services, is pleased to announce that it has raised a total of £650,000 by way of a further loan from NW1 Investments. The new loan is repayable by 31 July 2017, in line with the Group's other loans from NW1 and will accrue interest at a rate of 2.5% per annum above the base lending rate of the Bank of England from time to time payable quarterly in arrears. The Company intends to use the funds for near term working capital purposes, in particular for the growth of the recently launched Kiqplan Version 2.

 

Chief Executive Anna Gudmundson said: "NW1 advanced these further funds as they are pleased with the progress which the Group has made since the fundraising in August 2015. The Group has recruited some very talented people and has launched Version 2 of Kiqplan in line with the Board's expectations and laying the foundations on which to build our digital business. I am looking forward to growing our digital business significantly in 2016."

 

**ENDS**

 

For further information visit www.kiqplan.com or www.fitbugholdings.com contact:

 

 

Donald Stewart/ Anna Gudmundson

 

Fitbug Holdings Plc

020 7449 1000

Marc Milmo/ Catherine Leftley

Cantor Fitzgerald Europe, Nomad and Joint Broker

 

020 7894 7000

Claire Louise Noyce / William Lynne / Niall Pearson

 

Hybridan LLP, Joint Broker

0203 713 4581/4582/4583

Elisabeth Cowell / Charlotte Heap

St Brides Partners Ltd, Public Relations

020 7236 1177

 

Notes

About Fitbug®

Fitbug is a leading provider of online health and well-being services to help individuals to improve their lifestyles by making realistic changes to their daily routine. It combines activity tracking devices, which download to the Fitbug app and fitbug.com to provide an understanding of each user's daily activity achievements, with mobile and web technology which provides users with personalised weekly activity and nutrition targets, feedback, advice and encouragement.

 

Its "Kiqplan"TM digital health coaching platform is designed to make wearable technology relevant to new audiences and take the "so what?" out of activity tracking by providing structured action plans to help people get fitter, lighter and lead happier, healthier lives.

 

Key market sectors and distribution channels include retail, health insurance and rewards providers, workplace health programmes, fitness operators and consumers. An important part of the Company's focus is on building strategic partnerships with organisations which can integrate Fitbug or Kiqplan into their own service/product offerings or resell to their customer base. The Company has operations in the UK and United States. For more information, visit www.fitbug.com and www.kiqplan.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCTJBTTMBATBJA
Date   Source Headline
22nd Apr 20217:00 amRNSAnnual General Meeting Statement
7th Apr 20214:41 pmRNSSecond Price Monitoring Extn
7th Apr 20214:36 pmRNSPrice Monitoring Extension
31st Mar 20216:11 pmRNSPosting of Annual Report & Accounts, Notice of AGM
26th Mar 20217:00 amRNSPreliminary Results for the y/e 31 December 2020
12th Feb 202110:00 amRNSBidstack teams up with Moat by Oracle
2nd Feb 20219:05 amRNSSecond Price Monitoring Extn
2nd Feb 20219:00 amRNSPrice Monitoring Extension
1st Feb 20219:05 amRNSSecond Price Monitoring Extn
1st Feb 20219:00 amRNSPrice Monitoring Extension
1st Feb 20217:00 amRNSTrading Update and Directorate Change
21st Jan 202111:05 amRNSSecond Price Monitoring Extn
21st Jan 202111:00 amRNSPrice Monitoring Extension
6th Jan 20212:05 pmRNSSecond Price Monitoring Extn
6th Jan 20212:00 pmRNSPrice Monitoring Extension
6th Jan 202111:05 amRNSSecond Price Monitoring Extn
6th Jan 202111:00 amRNSPrice Monitoring Extension
4th Jan 20214:41 pmRNSSecond Price Monitoring Extn
4th Jan 20214:36 pmRNSPrice Monitoring Extension
4th Jan 20212:06 pmRNSSecond Price Monitoring Extn
4th Jan 20212:00 pmRNSPrice Monitoring Extension
4th Jan 202111:05 amRNSSecond Price Monitoring Extn
4th Jan 202111:00 amRNSPrice Monitoring Extension
23rd Dec 20205:15 pmRNSBlock Listing Six Monthly Return
21st Dec 202011:00 amRNSPrice Monitoring Extension
17th Dec 20209:05 amRNSSecond Price Monitoring Extn
17th Dec 20209:00 amRNSPrice Monitoring Extension
17th Dec 20207:00 amRNSTrading Update
4th Dec 20204:41 pmRNSSecond Price Monitoring Extn
4th Dec 20204:36 pmRNSPrice Monitoring Extension
16th Nov 20202:40 pmRNSExercise of Warrants, Issue of Equity and TVR
11th Nov 20202:51 pmRNSExercise of Warrants, Issue of Equity and TVR
29th Oct 20201:20 pmRNSExercise of Warrants and Total Voting Rights
27th Oct 20208:38 amRNSBlock Listing Six Monthly Return
2nd Oct 20204:35 pmRNSPrice Monitoring Extension
24th Sep 202011:05 amRNSSecond Price Monitoring Extn
24th Sep 202011:00 amRNSPrice Monitoring Extension
24th Sep 20209:05 amRNSSecond Price Monitoring Extn
24th Sep 20209:00 amRNSPrice Monitoring Extension
23rd Sep 20204:40 pmRNSSecond Price Monitoring Extn
23rd Sep 20204:35 pmRNSPrice Monitoring Extension
15th Sep 202011:05 amRNSSecond Price Monitoring Extn
15th Sep 202011:00 amRNSPrice Monitoring Extension
15th Sep 20207:00 amRNSExclusive Agreement with Ubisoft for Hyper Scape
19th Aug 20204:41 pmRNSSecond Price Monitoring Extn
19th Aug 20204:35 pmRNSPrice Monitoring Extension
18th Aug 20204:40 pmRNSSecond Price Monitoring Extn
18th Aug 20204:35 pmRNSPrice Monitoring Extension
18th Aug 20207:00 amRNSInterim Results
17th Aug 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.